© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
April 22, 2019
Bleeding in patients with nonvalvular atrial fibrillation and coronary syndrome was reduced by apixaban versus vitamin K antagonists.
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
March 15, 2019
Study finds different anticoagulation treatment levels for patients with cognitive problems.
A meta-analysis of 95 studies indicates lower risk of stroke and intracranial hemorrhage.
February 26, 2019
Higher-dose tofacitinib linked to greater risk of pulmonary embolism in RA patients.
February 18, 2019
What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.
February 16, 2019
DOACs are as good as warfarin in preventing atrial fibrillation complications.
Three cardiology groups now recommend using NOACs over warfarin in atrial fibrillation.
January 14, 2019
Black patients with atrial fibrillation are less likely to be treated with oral anticoagulants or DOACs.
January 11, 2019
The risk of gastrointestinal bleeding appears to be highest with rivaroxaban and lowest with apixaban, but is reduced by cotherapy with proton pump inhibitors.